Figure 3.

In vitro experiments. Circ‐SMARCA5 expression in NSCLC cell lines and normal lung bronchus epithelial cell line (A). Cell proliferation (B), cell viability under cisplatin treatment (C), cell viability under gemcitabine treatment (D), and IC₅₀ value (E) in circ‐SMARCA5 upregulation treated NCI‐H1437 cells and control NCI‐H1437 cells. Cell proliferation (F), cell viability under cisplatin treatment (G), cell viability under gemcitabine treatment (H), and IC₅₀ value (I) in circ‐SMARCA5 upregulation treated NCI‐H1299 cells and control NCI‐H1299 cells. Circ‐SMARCA5, circular RNA SMARCA5; IC₅₀, drug concentration required to inhibit growth by 50%